Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice

被引:42
作者
Dalseg, R
Wedege, E
Holst, J
Haugen, IL
Hoiby, EA
Haneberg, B
机构
[1] Natl Inst Publ Hlth, Dept Vaccinol, N-0403 Oslo, Norway
[2] Natl Inst Publ Hlth, Dept Bacteriol, N-0403 Oslo, Norway
[3] Univ Oslo, Inst Pharm, Dept Microbiol, N-0316 Oslo, Norway
关键词
mucosal immunization; Neisseria meningitidis; antibodies; memory;
D O I
10.1016/S0264-410X(99)00046-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Outer membrane vesicles (OMVs) from group B meningococci induced both serum and mucosal antibodies when given as a nasal and rectal vaccine to mice. Cholera toxin (CT) enhanced the antibody responses in serum both after nasal and rectal immunizations, and the mucosal responses after rectal immunizations only. Nasal immunizations, however, were most effective, with mucosal responses which were not dependent on the use of CT. The serum bactericidal activity was similarly not enhanced by CT, indicating that the positive effect of CT on the serum IgG level was not including bactericidal activity. A small nasal booster dose induced antibody responses in serum as far as eight months after intranasal and subcutaneous immunizations, and in saliva after intranasal immunizations. Nasal vaccines may thus be favorably combined with parenteral vaccines. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2336 / 2345
页数:10
相关论文
共 48 条
  • [1] INTRANASAL IMMUNIZATION WITH BACTERIAL POLYSACCHARIDE CONTAINING LIPOSOMES ENHANCES ANTIGEN-SPECIFIC PULMONARY SECRETORY ANTIBODY-RESPONSE
    ABRAHAM, E
    [J]. VACCINE, 1992, 10 (07) : 461 - 468
  • [2] APICELLA MA, 1995, PRINCIPLES PRACTICE, P1896
  • [3] Berstad AKH, 1997, VACCINE, V15, P1473
  • [4] EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY
    BJUNE, G
    HOIBY, EA
    GRONNESBY, JK
    ARNESEN, O
    HOLSTFREDRIKSEN, J
    HALSTENSEN, A
    HOLTEN, E
    LINDBAK, AK
    NOKLEBY, H
    ROSENQVIST, E
    SOLBERG, LK
    CLOSS, O
    ENG, J
    FROHOLM, LO
    LYSTAD, A
    BAKKETEIG, LS
    HAREIDE, B
    [J]. LANCET, 1991, 338 (8775) : 1093 - 1096
  • [5] ADJUVANT ACTIVITY OF ESCHERICHIA-COLI HEAT-LABILE ENTERO-TOXIN AND EFFECT ON THE INDUCTION OF ORAL TOLERANCE IN MICE TO UNRELATED PROTEIN ANTIGENS
    CLEMENTS, JD
    HARTZOG, NM
    LYON, FL
    [J]. VACCINE, 1988, 6 (03) : 269 - 277
  • [6] Dalseg R, 1996, VACCINES, P177
  • [7] DEHAAN A, 1995, VACCINE, V13, P613
  • [8] Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: Role of the A subunit
    deHaan, L
    Holtrop, M
    Verweij, WR
    Agsteribbe, E
    Wilschut, J
    [J]. VACCINE, 1996, 14 (04) : 260 - 266
  • [9] ELSON CO, 1984, J IMMUNOL, V132, P2736
  • [10] INDUCTION OF SYSTEMIC AND MUCOSAL IMMUNE-RESPONSES FOLLOWING IMMUNIZATION WITH SOMATOSTATIN AVIDIN COMPLEXES INCORPORATED INTO ISCOMS
    ESTRADA, A
    LAARVELD, B
    LI, B
    REDMOND, MJ
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 1995, 24 (05) : 819 - 828